Idioma:

Oral HIV-associated Kaposi sarcoma

Pantanowitz, L. ; Khammissa, R. A. G. ; Lemmer, J. ; Feller, L.

Journal of oral pathology & medicine, 2013-03, Vol.42 (3), p.201-207 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por

Enviar para

Título:
Oral HIV-associated Kaposi sarcoma
Autor: Pantanowitz, L. ; Khammissa, R. A. G. ; Lemmer, J. ; Feller, L.
Assuntos: AIDS ; AIDS-Related Opportunistic Infections - drug therapy ; AIDS-Related Opportunistic Infections - pathology ; Anti-Retroviral Agents - therapeutic use ; Antiretroviral Therapy, Highly Active ; Biological and medical sciences ; Dentistry ; Dermatology ; HAART ; Herpesvirus 8, Human - physiology ; HHV8 ; HIV ; HIV Infections - pathology ; Human herpesvirus 8 ; Human viral diseases ; Humans ; Infectious diseases ; IRIS ; Kaposi sarcoma ; Lymphedema - pathology ; Medical sciences ; mouth ; Mouth Neoplasms - drug therapy ; Mouth Neoplasms - pathology ; mucosa ; oral ; Otorhinolaryngology. Stomatology ; Sarcoma, Kaposi - drug therapy ; Sarcoma, Kaposi - pathology ; Tumors of the skin and soft tissue. Premalignant lesions ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids
É parte de: Journal of oral pathology & medicine, 2013-03, Vol.42 (3), p.201-207
Notas: ark:/67375/WNG-BHJ13RMB-N
ArticleID:JOP1180
istex:A0A410A55407612407B53F47C4868210C88AB512
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Feature-1
Descrição: J Oral Pathol Med (2012) Kaposi sarcoma (KS), an AIDS defining condition, remains one of the most commonly HIV‐associated neoplasms. While the use of highly active antiretroviral therapy (HAART) has brought about a dramatic decrease in the prevalence and incidence of AIDS‐KS worldwide, this has not been the case in resource‐poor sub‐Saharan African countries, where HIV has reached epidemic proportions and human herpesvirus‐8 infection is endemic. Oral involvement is a common manifestation of AIDS‐associated KS and may be an early presenting finding of HIV infection. The clinical manifestation of oral KS can vary and may have an unpredictable course ranging from mild to fulminant. Rapidly progressive facial lymphoedema associated with extensive advanced oral KS portends a poor prognosis. Oral KS may regress with antiretroviral therapy or may flare up as part of the immune reconstitution inflammatory syndrome. The oral lesions of AIDS‐KS are best managed with HAART together with systemic chemotherapy. This article provides a review of contemporary knowledge of the biology, pathology, clinical features and management of oral AIDS‐KS.
Editor: Oxford, UK: Blackwell Publishing Ltd
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Oral HIV-associated Kaposi sarcoma

Pantanowitz, L. ; Khammissa, R. A. G. ; Lemmer, J. ; Feller, L.

Oxford, UK: Blackwell Publishing Ltd

Buscando em bases de dados remotas. Favor aguardar.